In clinical trials of GLP-1 medications, fat loss far outweighs losses of lean mass
It has been used under medical supervision in specific pregnancy-related clinical contexts
In univariable analyses conducted on nondiabetic adults with overweight (BMI 25) or obesity (BMI 30), LEAP2 concentrations were found to be positively associated with fasting insulin, and first-phase and second-phase insulin secretion during intravenous glucose tolerance tests (149)
It usually takes at least 21 days before the candidate can start observing the benefits of glutathione
If you've lost less than 5%, options include: Titrating to a higher Zepbound dose Adding a second medication (e.g., metformin, topiramate) Switching to a different GLP-1 or GLP-1/GIP medication Reassessing diet, exercise, and behavioral factors Most patients who switch from Wegovy to Zepbound and titrate to at least 7.5 mg reach the 5% threshold by week 16
However, this is an off-label practice, and it is not yet clear whether using sub-clinical doses are either effective or safe